UMIN-CTR Clinical Trial

Basic information
Public title	Individual differences in the influence of similarity to the self-face on the face preference of others and its neural basis
Acronym	Individual differences in the influence of similarity to the self-face on the face preference of others and its neural basis
Scientific Title	Individual differences in the influence of similarity to the self-face on the face preference of others and its neural basis
Scientific Title:Acronym	Individual differences in the influence of similarity to the self-face on the face preference of others and its neural basis
Region	Japan

Condition
Condition	Healthy person
Classification by specialty	Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	The purpose of this study is to clarify the neural basis for judging the degree of similarity to the self-face and the neural basis for face preference for university students.
Basic objectives2	Others
Basic objectives -Others	Individual differences
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	Brain activity data
Key secondary outcomes

Base
Study type	Interventional

Study design
Basic design	Single arm
Randomization	Non-randomized
Randomization unit
Blinding	Open -no one is blinded
Control	Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	1
Purpose of intervention	Educational,Counseling,Training
Type of intervention	Device,equipment
Interventions/Control_1	Imaging with fMRI
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	18 years-old <=
Age-upper limit	28 years-old >=
Gender	Female
Key inclusion criteria	Healthy university and graduate students
Key exclusion criteria	1.Those who have a history of mental illness or cranial nerve disease 2.Those who are taking drugs that affect cognitive function (eg benzodiazepines, antidepressants, central nervous system drugs) 3.Those who are currently participating in other studies or who have participated in other studies within 2 months before the start of the study 4.Those who have metal in their body 5.For claustrophobia 6.Extreme myopia
Target sample size	40

Research contact person
Name of lead principal investigator	1st name Ryuta Middle name Last name Kawashima
Organization	Institute of Development, Aging and Cancer (IDAC), TOHOKU UNIVERSITY
Division name	Functional Brain Imaging
Zip code	980-8575
Address	4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan
TEL	022-717-7988
Email	fbi@grp.tohoku.ac.jo

Public contact
Name of contact person	1st name Ryuta Middle name Last name Kawashima
Organization	Institute of Development, Aging and Cancer (IDAC), TOHOKU UNIVERSITY
Division name	Functional Brain Imaging
Zip code	980-8575
Address	4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan
TEL	022-717-7988
Homepage URL
Email	fbi@grp.tohoku.ac.jo

Sponsor
Institute	Functional Brain Imaging, Institute of Development, Aging and Cancer (IDAC), TOHOKU UNIVERSITY
Institute
Department

Funding Source
Organization	None
Organization
Division
Category of Funding Organization	Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Ethics Committee Tohoku University Graduate School of Medicine
Address	2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan
Tel	022-717-8007
Email	med-kenkyo@grp.tohoku.ac.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2019 Year 11 Month 18 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Preinitiation
Date of protocol fixation	2019 Year 03 Month 15 Day
Date of IRB
Anticipated trial start date	2019 Year 11 Month 20 Day
Last follow-up date	2020 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date	2019 Year 11 Month 18 Day
Last modified on	2019 Year 11 Month 18 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044015